| Sources | Names Used |
|---|---|
| CTRPv2 | BRD-K30019337 |
| PharmacoGx | BRD-K30019337 |
| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CEP89 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.07 |
| mRNA | RASSF6 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.07 |
| mRNA | C12orf10 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.07 |
| mRNA | MRPL53 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.07 |
| mRNA | VCL | CTRPv2 | pan-cancer | AAC | -0.14 | 0.07 |
| mRNA | CDC42BPB | CTRPv2 | pan-cancer | AAC | 0.15 | 0.07 |
| mRNA | HIRIP3 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.07 |
| mRNA | HP1BP3 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.07 |
| mRNA | ZNF75D | CTRPv2 | pan-cancer | AAC | 0.13 | 0.07 |
| mRNA | USMG5 | CTRPv2 | pan-cancer | AAC | -0.14 | 0.07 |
